A Breakthrough for Hepatitis C (Video)
For the 4 million people in the United States with a hepatitis C infection, treatment options have improved greatly in the past three years.
Until 2011, there were no proven medicines for patients who didn’t respond to traditional therapy for this liver disease. That year, two new drugs— telaprevir and boceprevir—made Cleveland Clinic’s top 10 innovations list and changed the prospects for patients in need. This year, yet another promising option makes the list: sofosbuvir, the first all-oral hepatitis C treatment.
Watch the video.